Alinix

Alinix100 mg/5 ml

Powder for Suspension

Nitazoxanide

Healthcare Pharmaceuticals Ltd.

Product Code : 587
MRP 35.00
8% Off
Best PriceTk
/
Out Of Stock
1
Section

Medicine overview

Indications of Alinix 100 mg/5 ml

Alinix 100 mg/5 ml is indicated for the treatment of diarrhea caused by Cryptosporidium parvum, Giardia lamblia and Entamoeba histolytica.

Theropeutic Class

Anti-diarrhoeal Antiprotozoal

Pharmacology

Alinix 100 mg/5 ml is a synthetic antiprotozoal agent for oral administration. The antiprotozoal activity of Alinix 100 mg/5 ml is believed to be interference with the Pyruvate Ferredoxin Oxido Reductase (PFOR) enzyme-dependant electron transfer reaction. This reaction is essential for anaerobic energy metabolism of the protozoa. Alinix 100 mg/5 ml and its metabolites, tizoxanid are active in vitro in inhibiting the growth of sporozoites and oocyst of Cryptosporidium parvum and trophozoites of Giardia lamblia.

Dosage & Administration of Alinix 100 mg/5 ml

Age 1-3 years: 1 tea-spoonfull or 5 ml suspension every 12 hours for 3 days. Age 4-11 years: 2 tea-spoonfulls or 10 ml suspension every 12 hours for 3 days.Age 12 years or above: 5 tea-spoonfulls (25 ml) suspension or 1 tablet every 12 hours for 3 days. It is recommended to be administered with food.

Dosage of Alinix 100 mg/5 ml

Age 1-3 years: 1 tea-spoonfull or 5 ml suspension every 12 hours for 3 days. Age 4-11 years: 2 tea-spoonfulls or 10 ml suspension every 12 hours for 3 days.Age 12 years or above: 5 tea-spoonfulls (25 ml) suspension or 1 tablet every 12 hours for 3 days. It is recommended to be administered with food.

Interaction of Alinix 100 mg/5 ml

It is highly bound to plasma protein. Therefore, caution should be exercised when administering Alinix 100 mg/5 ml concurrently with other highly plasma protein-bound drugs with narrow therapeutic index.

Contraindications

It is contraindicated in patients with known hypersensitivity to Alinix 100 mg/5 ml or any components of the preparation.

Side Effects of Alinix 100 mg/5 ml

The most frequent side effects, reported by Alinix 100 mg/5 ml are abdominal pain, vomiting and headache. These side effects are typically mild and transient in nature. Very rare side effects include- nausea, anorexia, flatulence, increased appetite, enlarged salivary glands, increased creatinine & SGPT level, pruritus, rhinitis, sweating, dizziness, discolored urine etc.

Pregnancy & Lactation

US FDA pregnancy category of Alinix 100 mg/5 ml is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Alinix 100 mg/5 ml have been shown to be excreted in human milk. So, caution should be exercised when Alinix 100 mg/5 ml is administered during lactation.

Precautions & Warnings

Alinix 100 mg/5 ml must be administered with caution to patients with hepatic & biliary disease and to patients with renal disease.

Storage Conditions

Keep in a dry place away from light and heat. Keep out of the reach of children.

Drug Classes

Anti-diarrhoeal Antiprotozoal

Mode Of Action

Alinix 100 mg/5 ml is a synthetic antiprotozoal agent for oral administration. The antiprotozoal activity of Alinix 100 mg/5 ml is believed to be interference with the Pyruvate Ferredoxin Oxido Reductase (PFOR) enzyme-dependant electron transfer reaction. This reaction is essential for anaerobic energy metabolism of the protozoa. Alinix 100 mg/5 ml and its metabolites, tizoxanid are active in vitro in inhibiting the growth of sporozoites and oocyst of Cryptosporidium parvum and trophozoites of Giardia lamblia.

Pregnancy

US FDA pregnancy category of Alinix 100 mg/5 ml is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Alinix 100 mg/5 ml have been shown to be excreted in human milk. So, caution should be exercised when Alinix 100 mg/5 ml is administered during lactation.
Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.